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Commonly deleted region on the long arm of
chromosome 7 in differentiated adenocarcinoma of the
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Summary Loss of heterozygosity (LOH) at several chromosomal loci is a common event in human malignancies. Frequent LOH on the long
arm of chromosome 7 has been reported in various human malignancies, and investigators have identified the most common site of LOH as
7q31.1. We have identified ten chromosomal loci, including chromosome 7q, that have been shown by previous allelotype study to be sites of
frequent LOH in differentiated adenocarcinoma of the stomach. In the present study, we performed a polymerase chain reaction (PCR)
microsatellite analysis to define the common deleted region on 7q, using 14 polymorphic microsatellite markers in matched tumour and non-
tumour DNAs from 53 patients with primary gastric carcinoma of the differentiated type. LOH at any locus on 7q occurred in 34% (18 out of
53) of the tumours. Although many tumours exhibited total or large interstitial deletions, we determined the smallest common deleted region
to be at D7S480 (7q31.1). This is identical to the region identified for other human malignancies. These observations indicate that a putative
tumour suppressor gene at 7q31.1 may be involved in the pathogenesis of differentiated adenocarcinoma of the stomach.
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Gastric carcinoma is the second most common cause of cancer-
related deaths in the world (Whelan et al, 1993). The death rate for
this malignancy in China, Eastern Europe, South America and
Japan is much higher than in other parts ofthe world (Parker et al,
1996). In Japan in particular, gastric carcinoma is the most
common malignancy, with 47 000 Japanese dying ofthe disease in
1993 (Ministry ofHealth and Welfare, Japan).
Gastric carcinomas are classified histologically into differenti-
ated and undifferentiated, and it is thought that these distinct histo-
logical types may develop through different genetic pathways
(Tahara et al, 1993). Some investigators have postulated that
differentiated adenocarcinoma of the stomach may arise from a
pre-existing adenoma (Kihana et al, 1991; Tahara, 1993).
However, the sequential accumulation ofgenetic alterations char-
acteristic ofthe colorectal adenoma-carcinoma sequence have not
been demonstrated in adenomas and differentiated adenocarci-
noma of the stomach (Maesawa et al, 1995). These alterations
include mutations oftheAPC(adenomatous polyposis coli), K-ras
and p53 genes and deletion of the DCC (deleted in the colon
carcinoma) gene (Vogelstein et al, 1988; Baker et al, 1990;
Kikuchi-Yanoshita et al, 1992; Powell et al, 1992). In addition,
molecular analyses of gastric adenomas have demonstrated the
genetic stability of this tumour type (Tamura et al, 1994; 1995;
Maesawa et al, 1995).
Frequent loss of heterozygosity (LOH) at a given chromosomal
region has beeninterpreted as evidence that the affectedregion may
contain a tumour-suppressor gene that is inactivated during the
neoplastic process (Knudson, 1985). In gastric carcinoma, frequent
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LOH has been reported on Ip, lq, 3p, 5q, 7q, lIp, llq, 12q, 17p,
18q and 21q (Sano et al, 1991; Uchino et al, 1992; Kuniyasu et al,
1994; Schneider et al, 1995; Baffa et al, 1996; Ezaki et al, 1996;
Sakata et al, 1997). Our recent allelotype analysis detected frequent
LOH on 2q, 4p, Sq, 6p, 7q, llq, 14q, 17p, 18q and 21q in differen-
tiated adenocarcinoma of the stomach (Tamura et al, 1996b). The
target of LOH on 17p is the p53 gene because concordant LOH
with a mutation on the remaining allele, the classic two-hit mecha-
nism for inactivation oftumour-suppressor genes (Knudson, 1985),
has been demonstrated (Tamura et al, 1991). In addition, we have
identified the minimum region of deletion on Sq and 21q by dele-
tion mapping using polymorphic microsatellite markers (Tamura et
al, 1996a; Sakata et al, 1997).
It has been reported that the tumorigenicity ofCH72, a cell line
derived from a murine squamous cell carcinoma, was suppressed
by the microcell-mediated introduction of human chromosome 7,
suggesting that a tumour-suppressor gene may exist proximal to
7q31.1-31.3 (Zenklusen et al, 1994a). Zenklusen et al (1995a)
have attempted to determine the location of a putative tumour
suppressorgene on7q for several tumourtypes and have narrowed
the locus down to a 1-cM region at 7q31.1. These studies have
suggested the existence of a putative tumour-suppressor gene on
7q that is involved in the pathogenesis of a wide range ofhuman
malignancies. In the present study, we assessed LOH on 7q with
polymorphic microsatellite markers to determine the common
deleted region in differentiated adenocarcinoma ofthe stomach.
MATERIALS AND METHODS
Samples
Fifty-three carcinomas and corresponding non-tumour tissues
were obtained surgically or endoscopically from 53 patients. A
portion of the tissue was frozen and stored at -800C for DNA
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Table 1 Loss of heterozygosity in differentiated gastric adenocarcinomas
Locus symbol Location Frequency of Frequency
informative cases of LOH
D7S527 7q21.3 28% (19/53) 21% (4/19)
D7S518 7q22 38% (20/53) 20% (4/20)
D7S496 7q31 64% (34/53) 12% (4/34)
D7S523 7q31.1 47% (25/53) 20% (5/25)
D7S486 7q31.1 57% (30/53) 20% (6/30)
D7S633 7q31.1 45% (24/53) 17% (4/24)
D7S677 7q31.1 36% (19/53) 11% (2/19)
D7S522 7q31.1 36% (19/53) 26% (5/19)
D7S655 7q31.1 36% (19/53) 42% (8/19)
D7S480 7q31.1 47% (25/53) 36% (9/25)
D7S490 7q31.1 47% (25/53) 28% (7/25)
D7S487 7q31.1 55% (29/53) 35% (10/29)
D7S498 7q31-qter 36% (19/53) 21% (4/19)
D7S550 7q36 45% (24/53) 21% (5/24)
extraction, and the remaining tissue was fixed in 10% buffered
formalin for histological examination. The carcinomas were
differentiated adenocarcinomas and consisted of20 early (depth of
invasion limited to the mucosa or submucosa) and 33 advanced
carcinomas, in which the depth ofinvasion reached the muscularis
propria in eight cases and was beyond the muscularis propria in 25
cases, according to the Japanese Research Society for Gastric
Cancer criteria (1993). Nodal metastasis was present in none ofthe
20 early carcinomas and 24 ofthe 33 advanced carcinomas.
DNA extraction
DNA was isolated by a standard proteinase K digestion and
phenol-chloroform extraction procedure.
PCR and microsatellite analysis
Fourteen microsatellite markers were used: D7S527, D7S518,
D7S496, D7S523, D7S486, D7S633, D7S677, D7S522, D7S655,
D7S480, D7S490, D7S487, D7S498, and D7S550. Primers for
polymerase chain reaction (PCR) were obtained from MapPairs
(Research Genetics, Huntsville, AL, USA). These markers have
been mapped by Gyapay et al (1994) and Green et al (1994). The
extracted DNA was amplifiedbyPCR with 35 cycles, consisting of
a denaturation step at 94°C for 30 s, an annealing step at 55°C for
30 s and an elongation step at 720C for 1 min. PCR was performed
in a total volume of 10 ,ul of 1 x PCR buffer (50 mM potassium
chloride, 0.01% gelatin, and 10 mm Tris buffer, pH 8.3) containing
20 pM of each primer, 1 mm magnesium chloride, 0.2 mm of each
deoxynucleotide triphosphate, 0.5 units of AmpliTaq DNA poly-
merase (Perkin Elmer Cetus Corp, Norwalk, CT, USA), 0.5 jl of
[a-32P]dCTP (3000 Ci mmol-1, 10 Ci ml-') and 100 ng ofgenomic
DNA. Five microlitres ofthe PCR product were diluted with 45 ,l
of gel-loading buffer [98% formamide, 10 mM EDTA (pH 8.0),
0.025% xylene cyanol and 0.025% bromophenol blue], heated at
94°C for 2 min and stored on ice until analysis. Electrophoresis
was performed on a 6% polyacrylamide gel containing 7 M urea at
60 W for 2-2.5 h. The gel was fixed to Seq gel filter paper (Bio-
Rad, Hercules, CA, USA), dried on a vacuum slab gel dryer and
exposed to radiograph film at -800C for 12-24 h.
Figure 1 Polymerase chain reaction amplification of microsatellite markers
in two patients. Patient numbers are shown at the top of the respective lanes.
Loss of heterozygosity (LOH) is indicated by arrowheads. T, tumour DNA; N,
non-tumour DNA
Assessment of microsatellite alterations
LOH was defined as a visible change in the allele-allele ratio in
the tumour DNA relative to the ratio in the corresponding non-
tumour DNA. Alterations werejudged as replication errors (RER)
when additional bands not seen in the corresponding non-tumour
DNA appeared in the tumour DNA. Three reviewers determined
the intensity of bands by visual examination. A second PCR
microsatellite analysis was performed to ensure that the results
were reproducible in each case that showed LOH or RER.
Statistical analysis
The Abacus Concepts software program, StatView (Abacus
Concepts, Berkeley, CA, USA, 1992) was used for statistical
analysis. Relationships between LOH and clinicopathological
characteristics were evaluated using Fisher's exact test.
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Figure 2 Deletion map of 18 differentiated adenocarcinomas of the stomach (patient numbers: 16, 20, 66, 69, 102, 104, 110, 117, 119, 124, 134, 138, 139,
140, 147, 149, 151 and 161). An approximate physical map of microsatellite markers on 7q and results of the loss of heterozygosity (LOH) analysis at each
locus are shown on the right side of the karyogram. The tumours exhibiting 7q LOH are divided into four groups: total deletion (numbers 20, 102, 110, 117, 134,
138); large interstitial deletion (numbers 66, 69, 124, 139, 147, 149, 161); narrow deletion around D7S480 (numbers 16, 104, 119, 140); and deletion outside
and centromeric to 7q31.1 (number 151). *, Loss of heterozygosity; El, retaining heterozygosity i1, homozygosity; 0, replication error
RESULTS
Fourteen microsatellite markers were amplified by PCR to screen
53 differentiated adenocarcinomas for 7q LOH (Table 1). LOH
occurred in 34% (18 out of 53) of the tumours (Figure 1).
Although many tumours (patients 20, 102, 110, 117, 134, 138, 66,
69, 124, 139, 147, 149 and 161) exhibited total or large interstitial
deletions on 7q, including 7q31.1, we determined the minimum
region of deletion to be at D7S480 (Figure 2). Only one patient
(patient 151) showed LOH outside and centromeric to 7q31.1. No
significant correlation was observed between LOH and tumour
stage or nodal metastasis by Fisher's exact test. RER was present
in nine (17%) tumours and was more frequent in advanced (21%, 7
out of 33) than in early (10%, 2 out of 20) carcinomas, although
the difference was not statistically significant. RER was present at
multiple loci in six cases and at a single locus in the remaining
three cases. The incidence of informative cases was lower than
expected (Research Genetics, Huntsville, AL, USA), probably
owing to ethnic differences.
DISCUSSION
Functional inactivation of a tumour-suppressor gene often
involves deletion ofthe normal allele to unmask the mutated allele
(Chen et al, 1994). Chromosomal regions with frequent deletions
are therefore thought to harbour putative tumour suppressors
(Chen et al, 1994). The pathogenesis of gastric carcinoma is not
well understood, although many molecular genetic studies have
been performed. Investigators have demonstrated chromosomal
regions of deletion on ip, 3p, 5q, lq and 21q using polymorphic
markers (Schneider, 1995; Baffa et al, 1996; Ezaki, 1996; Tamura
et al, 1996a; Sakata et al, 1997). These regions are thought to
contain tumour-suppressor genes that influence the development
and progression ofgastric carcinomas.
Cytogenetic studies have revealed 7q chromosomal abnormali-
ties in several tumour types, including gastric carcinoma (Xiao et
al, 1992; Takahashi et al, 1994; Gomyo et al, 1995; Visscher et al,
1996). It has also been shown that intact human chromosome 7 can
suppress the tumorigenicity of carcinoma cell lines (Zenklusen et
al, 1994a). From the clinicopathological point of view, there are
reports that 7q LOH is a significant prognostic factor in some
cancers (Bieche et al, 1992; Kuniyasu et al, 1994; Takahashi et al,
1995). LOH on 7q has consequently been assumed to play acritical
role in the development or progression ofhuman malignancies.
The c-met proto-oncogene is located at 7q31.1. The c-met
protein has been identified as the cell-surface receptor for hepato-
cyte growth factor (Bottaro et al, 1991). LOH at 7q31.1 (c-met
locus) has been reported in breast carcinoma and well-differenti-
ated adenocarcinoma ofthe stomach (Bieche et al, 1992; Kuniyasu
et al, 1994). Zenklusen et al (1994b, c; 1995a, b) have used several
polymorphic microsatellite markers in an attempt to determine the
location of the putative tumour suppressor gene on 7q in carci-
nomas of the breast, prostate, head and neck, colon and ovary.
They have shown that the smallest common deleted region is distal
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to c-met at 7q31.1, with a normal distribution around the peak at
D7S522. Moreover, Takahashi et al (1995) have found two distinct
regions of deletion on 7q31 in prostate carcinomas. One was
located within the 1-cM region between D7S523 and D7S486, and
the other within the 3-cM region between D7S480 and D7S487
(Takahashi et al, 1995). These observations suggest that putative
tumour suppressor gene(s) for a wide range of human malignan-
cies exist(s) at 7q31.1.
In the present study, we have analysed 7q LOH using 14 poly-
morphic microsatellite markers in an attempt to clarify the targeted
locus that presumably contains a tumour suppressor gene impor-
tant in gastric and other cancers. Although we found that many of
the differentiated adenocarcinomas of the stomach exhibited total
or large interstitial deletions on 7q that included 7q31.1, the
smallest common deleted region was identified as the D7S480
locus. Although this region is located 1 cM from the smallest
common deleted region determined previously (Zenklusen et al,
1994b, c, 1995a, b), it coincides with another region of frequent
LOH nearest to the peak at D7S522 (Zenklusen et al, 1994b). The
smallest common deleted region at D7S480 is also identical to that
determined by Takahashi et al (1995). Therefore, the demonstra-
tion that the smallest common deleted region identified in this
study coincides with that found in other tumours suggests that the
same putative tumour suppressor gene contained within this region
is involved in the development or progression of several common
tumours, including differentiated adenocarcinoma ofthe stomach.
We found no significant correlation between 7q LOH and
tumour stage or nodal metastasis. In contrast, Kuniyasu et al
(1994) have demonstrated that deletion at D7S95 (7q31-35) was
closely associated with tumour progression, especially with peri-
toneal dissemination of gastric carcinoma. As their samples
consisted of both well-differentiated and poorly differentiated
tumours, it would be difficult to compare these results. However,
this phenomenon can be explained by hypothesizing that a cell
adhesion molecule, such as E-cadherin, would be encoded by the
putative tumour suppressor gene on 7q, because E-cadherin gene
inactivation is associated with such disseminating tumour growth
(Tamura et al, 1996c) and occurs even in its early stages (Muta et
al, 1996). However, as the analysis by Kuniyasu et al (1994) was
limited to advanced carcinomas, the significance ofLOH atD7S95
as an indicator ofdisseminated disease awaits a larger study.
In summary, the smallest common deleted region on 7q in
differentiated adenocarcinoma ofthe stomach is located very close
to that identified in other tumour types, and a major effort should
be directed towards cloning the candidate gene.
ACKNOWLEDGEMENTS
The authors are grateful to Drs Y Hirata, K Koeda and the
members ofthe Gastric Cancer Research Group at the Department
of Surgery, Iwate Medical University Hospital for providing
surgical materials. This work was supported in part by grants from
the Ministry ofEducation, Science, and Culture (0867012) and the
Ministry ofHealth and Welfare (S8-1), Japan.
REFERENCES
Baffa R, Negrini M, Mandes B, Rugge M, Ranzani GN, Hirohashi S and Croce CM
(1996) Loss of heterozygosity for chromosome 11 in adenocarcinoma of the
stomach. Cancer Res 56: 268-272
Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JKV,
Hamilton S and Vogelstein B (1990) p53 gene mutations occur in combination
with 17p allelic deletions as late events in colorectal tumorigenesis. CancerRes
50: 7717-7722
Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R and Lidereau R (1992)
Loss ofheterozygosity on chromosome 7q and aggressive primary breast
cancer. Lancet 339: 139-143
Bottaro DP, Rubin JS, Faletto DL, Chan AML, Kmiecik TE, Woude GFV and
Aaronson SA (1991) Identification ofthe hepatocyte growth factor receptor as
the c-met proto-oncogene product. Science 251: 802-804
Chen LC, Matsumura K, Deng G, Kurisu W, Ljung BM, Lerman MI, Waldman FM
and Smith HS (1994) Deletion oftwo separate regions on chromosome 3p in
breast cancers. Cancer Res 54: 3021-3024
Ezaki T, Yanagisawa A, Ohta K, Aiso S, Watanabe M, Hibi T, Kato Y,
Nakajima T, Ariyama T, Inazawa J, Nakamura Y and Horii A (1996) Deletion
mapping on chromosome Ip in well-differentiated gastric cancer. BrJ Cancer
73: 424-428
Gomyo Y, Andachi H, Nagao K, Ikeguchi M and Ito H (1995) Interphase
cytogenetics ofgastric carcinoma: fluorescence in situ hybridization (FISH)
applied to cells obtained from formalin-fixed paraffin-embedded tissues.
Pathol Int45: 227-232
Green ED, Idol JR, Mohr-Tidwell RM, Braden VV, Peluso DC, Fulton RS, Massa
HF, Magness CL, Wilson AM, Kimuara J, Weissenbach J and Trask BJ (1994)
Integration ofphysical, genetic and cytogenetic maps ofhuman chromosome 7:
isolation and analysis ofyeast artificial chromosome clones for 117 mapped
genetic markers. Hum Mol Genet3: 489-501
Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S,
Bemardi G, Lathrop M and Weissenbach J (1994) The 1993-94 Genethon
human genetic linkage map. Nature Genet 7: 246-339
Kihana T, Tsuda H, Hirota T, Shimosato Y, Sakamoto H, Terada M and Hirohashi S
(1991) Point mutation ofc-Ki-ras oncogene in gastric adenoma and
adenocarcinoma with tubular differentiation. Jpn J Cancer Res 82: 308-314
Kikuchi-Yanoshita R, Konishi M, Fukunari H, Tanaka K and Miyaki M (1992) Loss
ofexpression ofthe DCCgene during progression ofcolorectal carcinomas in
familial adenomatous polyposis and non-familial adenomatous polyposis
patients. CancerRes 52: 3801-3803
Knudson AG (1985) Hereditary cancer, oncogenes, and antioncogenes. Cancer Res
45:1437-1443
Kuniyasu H, Yasui W, Yokozaki H, Akagi M, Akama Y, Kitahara K, Fujii K and
Tahara E (1994) Frequent loss ofheterozygosity ofthe long arm of
chromosome 7 is closely associated with progression ofhuman gastric
carcinomas. IntJ Cancer59: 597-600
Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Sakata K, Kashiwaba M and
Satodate R (1995) The sequential accumulation ofgenetic alterations
characteristic ofthe colorectal adenoma-carcinoma sequence does not occur
between gastric adenoma and adenocarcinoma. JPathol 176: 249-258
Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H and Hirohashi S (1996)
E-cadherin gene mutations in signet ring cell carcinoma ofthe stomach.
Jpn J CancerRes 87: 843-848
Parker SL, Tong T, Bolden S and Wingo PA (1996) Cancer Statistics, 1996. CA
CancerJ Clin 65: 5-27
Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN,
Vogelstein B and Kinzler KW (1992) APC mutations occur early during
colorectal tumorigenesis. Nature 359: 235-237
Sakata K, Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M,
Saito K and Satodate R (1997) Commonly deleted regions on the long arm of
chromosome 21 in differentiated adenocarcinoma ofthe stomach. Genes
Chromosom Cancer 18: 318-321
Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y,
Kajiyama G and Tahara E (1991) Frequent loss ofheterozygosity on
chromosomes lq, Sq, and 17p in human gastric carcinomas. CancerRes 51:
2926-2931
Schneider BG, Pulitzer DR, Brown RD, Prihoda TJ, Bostwick DG, Saldivar V,
Rodrigez-Martinez HA, Guti6rrez-Diaz CME and O'Connell P (1995) Allelic
imbalance in gastric cancer: an affected site on chromosome arm 3p. Genes
Chromosom Cancer 13: 263-271
Tahara E (1993) Molecular mechanism ofstomach carcinogenesis. J CancerRes
Clin Oncol 119: 1-8
Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM and Jenkins
RB (1994) Potential markers ofprostate cancer aggressiveness detected by
fluorescence in situ hybridization in needle biopsies. CancerRes 54:
3574-3579
Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM,
Thibodeau SN and Jenkins RB (1995) Frequent loss ofheterozygosity at
British Journal ofCancer (1997) 76(12), 1567-1571 0 CancerResearch Campaign 1997Commonly deletedregion on 7q in gastric carcinoma 1571
'q31.1 in primary prostate cancer is associated with tumor aggressiveness and
progression. Cancer Res 55: 4114-4119
Tamura G, Kihana T, Nomura K, Terada M, Sugimura T and Hirohashi S (1991)
Detection offrequent p53 gene mutations in primary gastric cancer by cell
sorting and polymerase chain reaction single-strand conformation
polymorphism analysis. CancerRes 51: 3056-3058
Tamura G, Maesawa C, Suzuki Y, Tamada H, Satoh M, Ogasawara S, Kashiwaba M
and Satodate R (1994) Mutations oftheAPC gene occurduring early stages of
gastric adenoma development. CancerRes 54: 1149-1151
Tamura G, Sakata K, Maesawa C, Suzuki Y, Terashima M, Satoh K, Sekiyama S,
Suzuki A, Eda Y and Satodate R (1995) Microsatellite alterations in
adenoma and differentiated adenocarcinoma ofthe stomach. CancerRes 55:
1933-1936
Tamura G, Ogasawara S, Nishizuka S, Sakata K, Maesawa C, Suzuki Y, Terashima
M, Saito K and Satodate R (1996a) Two distinct regions ofdeletion on the long
arm ofchromosome 5 in differentiated adenocarcinomas ofthe stomach.
Cancer Res 56: 612-615
Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Terashima M, Eda Y and
Satodate R (1996b) Allelotype ofadenoma and differentiated adenocarcinoma
ofthe stomach. JPathol 180: 371-377
Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M,
Saito K and Satodate R (1996c) Inactivation ofthe E-cadherin gene in primary
gastric carcinomas and gastric carcinoma cell lines. Jpn J CancerRes 87:
1153-1159
Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M,
Sugimura T and Hirohashi S (1992) Frequent loss ofheterozygosity at the DCC
locus in gastric cancer. CancerRes 52: 3099-3102
Visscher DW, Wallis TL and Crissman JD (1996) Evaluation ofchromosome
aneuploidy in tissue sections ofpreinvasive breast carcinomas using interphase
cytogenetics. Cancer77: 315-320
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M,
Nakamura Y, White R, Smits AMM and Bos JL (1988) Genetic alterations
during colorectal-tumor development. NEngl JMed319: 525-532
Whelan SL, Parkin DM and Masuyer E eds (1993) Trends in Cancer Incidence and
Mortality. IARC Scientific Publication No. 102. IARC: Lyon, France
Xiao S, Geng JS, Feng XL, Liu XQ, Liu QZ and Li P (1992) Cytogenetic studies of
eight primary gastric cancers. Cancer Genet Cytogenet 58: 79-84
Zenklusen JC, Oshimura M, Barrett JC and Conti CJ (1994a) Inhibition of
tumorigenicity ofa murine squamous cell carcinoma (SCC) cell line by a
putative tumor suppressor gene on human chromosome 7. Oncogene 9:
2817-2825
Zenklusen JC, Bieche I, Lidereau R and Conti CJ (1994b) (C-A)n microsatellite
repeat D7S522 is the most commonly deleted region in human primary breast
cancer. Proc NatlAcadSci USA 91: 12155-12158
Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Conti CJ (1994c) Loss of
heterozygosity in human primary prostate carcinomas: a possible tumour
suppressor gene at 7q31.1. Cancer Res 54: 6370-6373
Zenklusen JC, Weitzel JN, Ball HG and Conti CJ (1995a) Allelic loss at 7q31.1 in
human primary ovarian carcinomas suggests the existence ofa tumor
suppressor gene. Oncogene 11: 359-363
Zenklusen JC, Thompson JC, Klein-Szanto AJP and Conti CJ (1995b) Frequent loss
ofheterozygosity in human primary squamous cell and colon carcinomas at
7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res 55:
1347-1350
© Cancer Research Campaign 1997 British Journal ofCancer (1997) 76(12), 1567-1571